Table 2.
Rate Ratios Comparing Invasive Pneumococcal Disease (IPD) Incidence Between HIV-Infected and HIV-Uninfected Adults
| Calendar era | Unadjusted RR (95% CI) | p | Adjusted RR (95% CI) | p |
|---|---|---|---|---|
| 1996–1999 | 27.4 (16.2–46.1) | <0.001 | 18.5 (10.8–31.8) | <0.001 |
| 2000–2003 | 21.0 (11.5–38.6) | <0.001 | 13.4 (6.9–25.7) | <0.001 |
| 2004–2007 | 24.3 (12.0–49.1) | <0.001 | 15.6 (7.4–33.0) | <0.001 |
| 2008–2009 | 8.1 (3.4–19.5) | <0.001 | 5.4 (2.2–13.5) | <0.001 |
| 2010–2011 | 9.7 (4.1–23.1) | <0.001 | 6.6 (2.7–16.1) | <0.001 |
Adjusted RRs derived from Poisson models, including variables for age, sex, race/ethnicity, SES, smoking, diabetes, hypertension, stroke, CHD, cancer, and PPV23 use.
CHD, coronary heart disease; CI, confidence interval; IPD, invasive pneumococcal disease; PPV, pneumococcal polysaccharide vaccine; RR, rate ratio; SES, socioeconomic status.